Latest News

Researchers surveyed nearly 5,000 women between ages 45 and 60 across four Mayo Clinic primary care locations.

Endocare plans to launch its obesity and metabolic care services in Riyadh within the coming months, building on its successful operations in Dubai and Abu Dhabi.

The upgraded laboratory streamlines sample processing from reception through advanced analysis and genetic sequencing.

Fakeeh University Hospital became the first facility in the region to administer Duvyzat (givinostat), an innovative therapy used to manage Duchenne muscular dystrophy (DMD).

This first-of-its-kind transplantation in Qatar highlights Sidra Medicine’s mission to provide advanced and innovative care for children with complex and high-risk diseases.

Through this acquisition, J&J gains access to HLD-0915, a clinical-stage, once-daily oral therapy intended for the treatment of prostate cancer.

NAFDAC’s decision came after assessing outcomes from these surgeries, which used the Toumai system manufactured by Shanghai MicroPort MedBot.

With this latest authorisation, individuals now have access to a long-acting option for prevention rather than daily pill-based regimens.

This deal gives Samsung Biologics its first manufacturing site in the US and reinforces its long-term commitment to serving the North American biopharmaceutical market.

The IAEA’s dosimetry audit is considered one of the most important global verification programmes for radiotherapy centres.